The FDA confirmed the nationwide shortage of sodium chloride 0.9% injection, or IV saline, has officially ended.
The IV saline shortage, which has affected hospitals and clinics across the country, is no longer listed in the FDA’s Drug Shortage Database, according to an Aug. 8 statement from agency Commissioner Marty Makary, MD. The FDA credited increased manufacturing capacity and temporary importation efforts for stabilizing supply.
In addition, to help address the shortage, Dr. Makary said the agency worked alongside the Administration for Strategic Preparedness and Response and other industry manufacturers to restore supply levels. While the sodium chloride 0.9% injection is considered stable, the agency noted in the statement that other IV solutions remain in short supply.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.